Related Experiment Video
Updated: Aug 31, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 15, 2011
Inadvertent administration of intravenous fluids contaminated with fungus
Abstract:
We present here the case of a patient inadvertently infused with intravenous fluid containing a "fungus ball." Because little is known about such cases, we surveyed 113 infectious diseases specialists for their experiences and ideas on management. Seventy-six responded, of whom 18 had seen a total of 24 cases. Intravenous-fluid containers were often defective, and the fungi involved were usually "contaminants." One patient developed significant fungal infection, and six others had transient symptoms temporally related to the infusion. Most specialists would administer antifungal therapy if symptoms developed, the patient was immunocompromised, or the fungus was pathogenic for humans.
Insights
A rare case of intravenous fluid contaminated with a fungus ball highlights risks. Most infectious disease specialists surveyed would treat patients with antifungal therapy if symptoms arise or the patient is immunocompromised.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Intravenous (IV) fluid contamination with fungal elements, such as a "fungus ball," is an uncommon but potentially serious clinical event.
- Limited data exists regarding the incidence, clinical significance, and optimal management of such occurrences.
Observation:
- A case report details a patient inadvertently receiving IV fluid containing a fungus ball.
- A survey of 113 infectious diseases specialists revealed 18 had encountered 24 such cases.
- Defective IV fluid containers were frequently implicated, with fungi often being contaminants.
Findings:
- One patient developed a significant fungal infection following the infusion.
- Six other patients experienced transient symptoms temporally associated with the contaminated infusion.
- Fungi identified were typically contaminants, but one instance led to invasive infection.
Implications:
- The findings underscore the importance of vigilance regarding IV fluid sterility.
- Specialists indicated a consensus towards administering antifungal therapy in specific scenarios: symptomatic patients, immunocompromised individuals, or infections by pathogenic fungi.
- Further research may be warranted to establish standardized management protocols for fungal contamination in IV fluids.
More Related Videos
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

